TIGIT and neoplasm: Moreover, TIGIT expression is upregulated in various tumour microenvironments—including colonic adenocarcinoma,92 non‐small cell lung cancer93 and acute myeloid leukaemia94—further facilitating the suppression of the anti‐tumoural immune response.